Gilead to launch human trials for inhaled form of remedsivir to treat coronavirus
Gilead to launch human trials for a version of remdesivir inhaled from a nebulizer that could treat coronavirus patients at home BFORE they are sick enough to be hospitalized Gilead Sciences said Monday that it is starting human trials for a version of its antiviral drug remdesivir that could be inhaled to treat coronavirus patients … Read more